Literature DB >> 33707760

The ability of baroreflex activation to improve blood pressure and resistance vessel function in spontaneously hypertensive rats is dependent on stimulation parameters.

Gean Domingos-Souza1,2, Fernanda Machado Santos-Almeida3, Cesar Arruda Meschiari4, Nathanne S Ferreira5, Camila A Pereira5, Nayara Pestana-Oliveira6, Thaís Caroline Prates-Costa3, Rita C Tostes5, Carl White7, Rubens Fazan3.   

Abstract

Baroreflex activation by electric stimulation of the carotid sinus (CS) effectively lowers blood pressure. However, the degree to which differences between stimulation protocols impinge on cardiovascular outcomes has not been defined. To address this, we examined the effects of short- and long-duration (SD and LD) CS stimulation on hemodynamic and vascular function in spontaneously hypertensive rats (SHRs). We fit animals with miniature electrical stimulators coupled to electrodes positioned around the left CS nerve that delivered intermittent 5/25 s ON/OFF (SD) or 20/20 s ON/OFF (LD) square pulses (1 ms, 3 V, 30 Hz) continuously applied for 48 h in conscious animals. A sham-operated control group was also studied. We measured mean arterial pressure (MAP), systolic blood pressure variability (SBPV), heart rate (HR), and heart rate variability (HRV) for 60 min before stimulation, 24 h into the protocol, and 60 min after stimulation had stopped. SD stimulation reversibly lowered MAP and HR during stimulation. LD stimulation evoked a decrease in MAP that was sustained even after stimulation was stopped. Neither SD nor LD had any effect on SBPV or HRV when recorded after stimulation, indicating no adaptation in autonomic activity. Both the contractile response to phenylephrine and the relaxation response to acetylcholine were increased in mesenteric resistance vessels isolated from LD-stimulated rats only. In conclusion, the ability of baroreflex activation to modulate hemodynamics and induce lasting vascular adaptation is critically dependent on the electrical parameters and duration of CS stimulation.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Baroreceptors; Carotid sinus; Hypertension; Mesenteric resistance arterioles.; Sympathetic activity

Mesh:

Year:  2021        PMID: 33707760     DOI: 10.1038/s41440-021-00639-9

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  58 in total

1.  Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.

Authors:  Teba Alnima; Ingrid Scheffers; Peter W De Leeuw; Bjorn Winkens; Heidi Jongen-Vancraybex; Jan H M Tordoir; Jürg Schmidli; Markus G Mohaupt; Yves Allemann; Abraham A Kroon
Journal:  J Hypertens       Date:  2012-08       Impact factor: 4.844

2.  An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

Authors:  Karl A Illig; Mark Levy; Luis Sanchez; Gregory D Trachiotis; Charles Shanley; Eric Irwin; Terry Pertile; Robert Kieval; Robert Cody
Journal:  J Vasc Surg       Date:  2006-12       Impact factor: 4.268

3.  An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.

Authors:  J H M Tordoir; I Scheffers; J Schmidli; H Savolainen; U Liebeskind; B Hansky; U Herold; E Irwin; A A Kroon; P de Leeuw; T K Peters; R Kieval; R Cody
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-01-16       Impact factor: 7.069

4.  Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

Authors:  John D Bisognano; George Bakris; Mitra K Nadim; Luis Sanchez; Abraham A Kroon; Jill Schafer; Peter W de Leeuw; Domenic A Sica
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

Review 5.  Baroreflex activation therapy systems: current status and future prospects.

Authors:  Gino Seravalle; Raffaella Dell'Oro; Guido Grassi
Journal:  Expert Rev Med Devices       Date:  2019-11-27       Impact factor: 3.166

6.  Bilateral or unilateral stimulation for baroreflex activation therapy.

Authors:  Peter W de Leeuw; Teba Alnima; Eric Lovett; Domenic Sica; John Bisognano; Hermann Haller; Abraham A Kroon
Journal:  Hypertension       Date:  2014-10-20       Impact factor: 10.190

7.  Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.

Authors:  William T Abraham; Michael R Zile; Fred A Weaver; Christian Butter; Anique Ducharme; Marcel Halbach; Didier Klug; Eric G Lovett; Jochen Müller-Ehmsen; Jill E Schafer; Michele Senni; Vijay Swarup; Rolf Wachter; William C Little
Journal:  JACC Heart Fail       Date:  2015-05-14       Impact factor: 12.035

8.  Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.

Authors:  Kerstin Wustmann; Jan P Kucera; Ingrid Scheffers; Markus Mohaupt; Abraham A Kroon; Peter W de Leeuw; Jürg Schmidli; Yves Allemann; Etienne Delacrétaz
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

9.  Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

Authors:  Karsten Heusser; Jens Tank; Stefan Engeli; André Diedrich; Jan Menne; Siegfried Eckert; Tim Peters; Fred C G J Sweep; Hermann Haller; Andreas M Pichlmaier; Friedrich C Luft; Jens Jordan
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

10.  Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Authors:  Edoardo Gronda; Gino Seravalle; Gianmaria Brambilla; Giuseppe Costantino; Andrea Casini; Ali Alsheraei; Eric G Lovett; Giuseppe Mancia; Guido Grassi
Journal:  Eur J Heart Fail       Date:  2014-07-28       Impact factor: 15.534

View more
  3 in total

1.  Low intensity stimulation of aortic baroreceptor afferent fibers as a potential therapeutic alternative for hypertension treatment.

Authors:  Ibrahim M Salman; Omar Z Ameer; Sheridan McMurray; Sarah F Hassan; Arun Sridhar; Stephen J Lewis; Yee-Hsee Hsieh
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

2.  Catheter-Based Radiofrequency Renal Sympathetic Denervation Decreases Left Ventricular Hypertrophy in Hypertensive Dogs.

Authors:  Shan Tu; Zhi-Jie Shen; Xiao-Yan Wang; Li-Xiong Zeng; Zhi-Hui Zhang
Journal:  Mediators Inflamm       Date:  2021-04-24       Impact factor: 4.711

Review 3.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.